Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation

Journal of Clinical Microbiology

Volumn 39, Issue 4, 2001, Pages 1422-1428

  Kronvall, G ^a   Karlsson, I ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; PYRROLE; VORICONAZOLE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CALIBRATION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; GROWTH INHIBITION; INTERMETHOD COMPARISON; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTIFUNGAL AGENTS; CALIBRATION; CANDIDA; CANDIDIASIS; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; ISSATCHENKIA ORIENTALIS;

EID: 0035059529     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.4.1422-1428.2001     Document Type: Article

References (44)

1. Fluconazole disk diffusion procedure for determining susceptibility of Candida species
2. Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Fluconazole Global Susceptibility Study Group
3. Types of interpretive errors in susceptibility testing
4. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis
5. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients
6. Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole
7. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing
8. An accurate diffusion method for determining bacterial sensitivity to antibiotics
9. Assessment of formulas for calculating critical concentration by the agar diffusion method
10. Antibiotic sensitivity testing. Report of an international collaborative study
11. Standardization of antifungal susceptibility testing and clinical relevance
12. Inter-laboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose
13. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains
14. Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter break-points in quality control of disk diffusion antibiotic susceptibility testing
15. Improving the accuracy of disc diffusion antibiotic susceptibility testing using species-related interpretive zone breakpoints
16. MIC determination of fusidic acid and of ciprofloxacin using multidisk diffusion tests
17. Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species
18. Antibiotic disk diffusion testing revisited. Single strain regression analysis
19. Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae
20. Calibration of disk diffusion antibiotic susceptibility testing: Species-related trovafloxacin interpretive zone break-points and selection of disk potency
21. Optimizing voriconazole susceptibility testing of Candida: Effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility
22. Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991
23. The use of fluconazole and itraconazole in the treatment of Candida albicans infections: A review
24. A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
25. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion
26. Fusidic acid disk diffusion testing of Clostridium difficile can be calibrated using SRA, single strain regression analysis
27. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: In vitro and clinical correlations
28. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis
29. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Sub-committee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards
30. Resistance of Candida species to fluconazole
31. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy
32. In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and-resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection
33. Detection of fluconazole-resistant Candida strains by a disc diffusion screening test
34. Testing susceptibility of fungi to fluconazole
35. Empfindlichkeitsprüfung von hefen gegenüber fluconazol: Vorschlag für eine standardisierte agardiffusions-methode mit 25-μg-fluconazol-testblättchen
36. Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole
37. Distribution of levels of penicillin resistance among freshly isolated strains of N. gonorrhoeae. Application of a novel sensitivity assay
38. Cross-resistance phenotypes of fluconazole-resistant Candida species: Results with 655 clinical isolates with different methods
39. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients
40. Candida, Cryptococcus, and other yeasts of medical importance
41. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
42. Clonal and spontaneous origins of fluconazole resistance in Candida albicans